CryoLife, Inc. (CRY) Tops Q2 EPS by 1c; Eases FY13 Outlook
Tweet Send to a Friend
CryoLife, Inc. (NYSE: CRY) reported Q2 EPS of $0.08, $0.01 better than the analyst estimate of $0.07 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
